In addition to being a contract manufacturer for a wide range of pharmaceutical clients, we also manufacture the following products.
Abelcet® (amphotericin B lipid complex injection) is a broad-spectrum antifungal used primarily in the hospital setting to treat fungal infections in patients with compromised immune systems, such as those undergoing treatment for cancer and recipients of organ or bone marrow transplants. Learn more at Leadiant.com.
Kalbitor® (ecallantide) is an anti-inflammatory kallikrein Inhibitor used to treat sudden, acute attacks of hereditary angioedema (HAE). Learn more at kalbitor.com
Krystexxa® (pegloticase) is used to treat chronic gout in adults whose symptoms haven't responded to other treatments. Pegloticase is an enzyme that metabolizes uric acid and dissolves gout crystals. Learn more at krystexxa.com.
Revcovi® (elapegademase-lvlr) is a new enzyme replacement therapy indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in both pediatric and adult patients. Elapegademase-lvlr is a PEGylated recombinant adenosine deaminase (rADA) enzyme developed by Leadiant Biosciences. Learn more at revcovi.com.
Oncaspar® (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase. Learn more at Oncaspar.com